Air Methods Reports 3Q2009 Results and 4Q2...(et 935 92...),Health

Date:11/5/2009

et 935 928 2,698 2,180 --- --- ----- ----- Income before income taxes 20,465 14,204 42,631 26,472 Income tax expense (7,861) (5,835) (16,387) (10,939) ------ ------ ------- ------- Net income $12,604 8,369 26,244 15,533 ======= ===== ====== ====== Income per common share: Basic $1.02 0.69 2.15 1.28 Diluted $1.01 0.67 2.12 1.23 Weighted average common shares outstanding: Basic 12,337,120 12,179,714 12,218,369 12,170,980 Diluted 12,498,320 12,522,932 12,397,026 12,590,252

SOURCE Air Methods Corporation

'/>"/>

SOURCE Air Methods Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
2. Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder
3. 10-State Project to Study Methods to Reduce Central Line-Associated Bloodstream Infections in Hospital ICUs
4. Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
5. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs